Talus Bio
YC S21 · Active · Discovering drugs that target the DNA regulome
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCS19 | |
| AI | Active | YCW15 | |
| AI | Active | YCS21 | |
| Other | Public | YCW15 | |
| Other | Active | YCW23 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCS19 | |
| AI | Inactive | YCW23 | |
| AI | Active | YCF25 | |
| AI | Active | YCW22 | |
| Other | Not stated | EF2019 |
Also from S21
All of S21About Talus Bio
We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.
- YC batch
- S21 · Summer 2021
- Status, per YC
- Active
- Category
- Other
- Team size
- 16
- Location
- Seattle, WA, USA
- Checked
- 1h ago
YC tags: Biotech, Genomics, Drug discovery
Talus Bio: questions
Which YC batch was Talus Bio in?
Talus Bio was in Y Combinator's Summer 2021 batch (S21).
Is Talus Bio still active?
Y Combinator lists Talus Bio as active.
Where is Talus Bio based?
Talus Bio lists Seattle, WA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.